ArticleACS pharmacology & translational science2023

Repurposing Ponatinib as a PD-L1 Inhibitor Revealed by Drug Repurposing Screening and Validation by

Anjali Barnwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.